North America Overactive Bladder Treatment Market by Manufacturers, Countries, Type and Application, Forecast to 2025
This report studies the Overactive Bladder Treatment market status and outlook of North America and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in North America and major regions, and splits the Overactive Bladder Treatment market by product and Application/end industries.
In the last several years, the development speed of Overactive Bladder Treatment market is huge changed. In 2017, the North America revenue market of Overactive Bladder Treatment was valued about 2842 million USD. With the development of generic and brand drugs, the market is still fast growing. In 2025, the North America revenue of Overactive Bladder Treatment is expected to be 5515 million USD with a CAGR of 8.64% between 2017 and 2025.
The major players in North America market include
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
Teva (Actavis)
Geographically, this report split North America into several key Regions, with, revenue (M USD), market share and growth rate of Overactive Bladder Treatment for these regions, from 2013 to 2025 (forecast)
USA
Canada
Mexico
On the basis of product, the Overactive Bladder Treatment market is primarily split into
Anticholinergics
Mirabegron
Botox
Other Drugs
On the basis on the end users/Application, this report covers
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
In the last several years, the development speed of Overactive Bladder Treatment market is huge changed. In 2017, the North America revenue market of Overactive Bladder Treatment was valued about 2842 million USD. With the development of generic and brand drugs, the market is still fast growing. In 2025, the North America revenue of Overactive Bladder Treatment is expected to be 5515 million USD with a CAGR of 8.64% between 2017 and 2025.
The major players in North America market include
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
Teva (Actavis)
Geographically, this report split North America into several key Regions, with, revenue (M USD), market share and growth rate of Overactive Bladder Treatment for these regions, from 2013 to 2025 (forecast)
USA
Canada
Mexico
On the basis of product, the Overactive Bladder Treatment market is primarily split into
Anticholinergics
Mirabegron
Botox
Other Drugs
On the basis on the end users/Application, this report covers
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
1 INDUSTRY OVERVIEW
1.1 Overactive Bladder Treatment Market Overview
1.1.1 Overactive Bladder Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 North America Overactive Bladder Treatment Market Size and Analysis by Regions (2013-2018)
1.2.1 United States Overactive Bladder Treatment Market Status and Outlook
1.2.2 Canada Overactive Bladder Treatment Market Status and Outlook
1.2.3 Mexico Overactive Bladder Treatment Market Status and Outlook
1.3 Classification of Overactive Bladder Treatment by Product
1.3.1 North America Overactive Bladder Treatment Revenue (M USD) Comparison by Product (2013-2025)
1.3.2 North America Overactive Bladder Treatment Revenue Market Share (%) by Product in 2017
1.3.3 Anticholinergics
1.3.4 Mirabegron
1.3.5 Botox
1.4 Overactive Bladder Treatment Market by End Users/Application
1.4.1 Idiopathic Overactive Bladder
1.4.2 Neurogenic Overactive Bladder
2 NORTH AMERICA OVERACTIVE BLADDER TREATMENT COMPETITION ANALYSIS BY PLAYERS
2.1 North America Overactive Bladder Treatment Market Size (M USD) by Players (2013-2018)
2.2 Competitive Status
2.3 Product Category of Overactive Bladder Treatment Players
3 COMPANY (TOP PLAYERS) PROFILES AND KEY DATA
3.1 Astellas Pharma
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 Revenue, Cost and Gross Margin
3.2 Allergan
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 Revenue, Cost and Gross Margin
3.3 Pfizer
3.3.1 Company Profile
3.3.2 Product Information
3.3.3 Revenue, Cost and Gross Margin
3.4 Teva Pharmaceutical (Actavis)
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 Revenue, Cost and Gross Margin
3.5 Johnson & Johnson
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 Revenue, Cost and Gross Margin
4 NORTH AMERICA OVERACTIVE BLADDER TREATMENT MARKET SIZE BY PRODUCT AND APPLICATION (2013-2018)
4.1 North America Overactive Bladder Treatment Market Size by Product (2013-2018)
4.2 North America Overactive Bladder Treatment Market Size by Application (2013-2018)
4.3 Top Consumer / End Users of Overactive Bladder Treatment
5 USA OVERACTIVE BLADDER TREATMENT DEVELOPMENT STATUS AND OUTLOOK
5.1 USA Overactive Bladder Treatment Market Size (2013-2018)
5.2 USA Overactive Bladder Treatment Market Size and Market Share by Types (2013-2018)
5.3 USA Overactive Bladder Treatment Market Size by Application (2013-2018)
6 CANADA OVERACTIVE BLADDER TREATMENT DEVELOPMENT STATUS AND OUTLOOK
6.1 Canada Overactive Bladder Treatment Market Size (2013-2018)
6.2 Canada Overactive Bladder Treatment Market Size and Market Share by Types (2013-2018)
6.3 Canada Overactive Bladder Treatment Market Size by Application (2013-2018)
7 MEXICO OVERACTIVE BLADDER TREATMENT DEVELOPMENT STATUS AND OUTLOOK
7.1 Mexico Overactive Bladder Treatment Market Size (2013-2018)
7.2 Mexico Overactive Bladder Treatment Market Size and Market Share by Types (2013-2018)
7.3 Mexico Overactive Bladder Treatment Market Size by Application (2013-2018)
8 MARKET FORECAST BY REGIONS, PRODUCT AND APPLICATION (2018-2025)
8.1 North America Overactive Bladder Treatment Market Size (M USD) by Regions (2018-2025)
8.1.1 United States Overactive Bladder Treatment Revenue and Growth Rate (2018-2025)
8.1.2 Canada Overactive Bladder Treatment Revenue and Growth Rate (2018-2025)
8.1.3 Mexico Overactive Bladder Treatment Revenue and Growth Rate (2018-2025)
8.2 North America Overactive Bladder Treatment Market Size by Application (2018-2025)
8.3 North America Overactive Bladder Treatment Market Size by Product (2018-2025)
9 OVERACTIVE BLADDER TREATMENT DRUG MANUFACTURING COST ANALYSIS
9.1 Overactive Bladder Treatment Drug Raw Materials Analysis
9.2 Overactive Bladder Treatment Drug R&D Cost Analysis
9.2.1 Clinical Phase Costs
9.2.2 Capitalized Costs
9.3 Proportion of Manufacturing Cost Structure
9.3.1 Raw Materials
9.3.2 Labor Cost Analysis
9.3.3 Other Costs Analysis
9.3.4 Manufacturing Expenses
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 RESEARCH FINDING /CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Disclaimer
12.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1.1 Overactive Bladder Treatment Market Overview
1.1.1 Overactive Bladder Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 North America Overactive Bladder Treatment Market Size and Analysis by Regions (2013-2018)
1.2.1 United States Overactive Bladder Treatment Market Status and Outlook
1.2.2 Canada Overactive Bladder Treatment Market Status and Outlook
1.2.3 Mexico Overactive Bladder Treatment Market Status and Outlook
1.3 Classification of Overactive Bladder Treatment by Product
1.3.1 North America Overactive Bladder Treatment Revenue (M USD) Comparison by Product (2013-2025)
1.3.2 North America Overactive Bladder Treatment Revenue Market Share (%) by Product in 2017
1.3.3 Anticholinergics
1.3.4 Mirabegron
1.3.5 Botox
1.4 Overactive Bladder Treatment Market by End Users/Application
1.4.1 Idiopathic Overactive Bladder
1.4.2 Neurogenic Overactive Bladder
2 NORTH AMERICA OVERACTIVE BLADDER TREATMENT COMPETITION ANALYSIS BY PLAYERS
2.1 North America Overactive Bladder Treatment Market Size (M USD) by Players (2013-2018)
2.2 Competitive Status
2.3 Product Category of Overactive Bladder Treatment Players
3 COMPANY (TOP PLAYERS) PROFILES AND KEY DATA
3.1 Astellas Pharma
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 Revenue, Cost and Gross Margin
3.2 Allergan
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 Revenue, Cost and Gross Margin
3.3 Pfizer
3.3.1 Company Profile
3.3.2 Product Information
3.3.3 Revenue, Cost and Gross Margin
3.4 Teva Pharmaceutical (Actavis)
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 Revenue, Cost and Gross Margin
3.5 Johnson & Johnson
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 Revenue, Cost and Gross Margin
4 NORTH AMERICA OVERACTIVE BLADDER TREATMENT MARKET SIZE BY PRODUCT AND APPLICATION (2013-2018)
4.1 North America Overactive Bladder Treatment Market Size by Product (2013-2018)
4.2 North America Overactive Bladder Treatment Market Size by Application (2013-2018)
4.3 Top Consumer / End Users of Overactive Bladder Treatment
5 USA OVERACTIVE BLADDER TREATMENT DEVELOPMENT STATUS AND OUTLOOK
5.1 USA Overactive Bladder Treatment Market Size (2013-2018)
5.2 USA Overactive Bladder Treatment Market Size and Market Share by Types (2013-2018)
5.3 USA Overactive Bladder Treatment Market Size by Application (2013-2018)
6 CANADA OVERACTIVE BLADDER TREATMENT DEVELOPMENT STATUS AND OUTLOOK
6.1 Canada Overactive Bladder Treatment Market Size (2013-2018)
6.2 Canada Overactive Bladder Treatment Market Size and Market Share by Types (2013-2018)
6.3 Canada Overactive Bladder Treatment Market Size by Application (2013-2018)
7 MEXICO OVERACTIVE BLADDER TREATMENT DEVELOPMENT STATUS AND OUTLOOK
7.1 Mexico Overactive Bladder Treatment Market Size (2013-2018)
7.2 Mexico Overactive Bladder Treatment Market Size and Market Share by Types (2013-2018)
7.3 Mexico Overactive Bladder Treatment Market Size by Application (2013-2018)
8 MARKET FORECAST BY REGIONS, PRODUCT AND APPLICATION (2018-2025)
8.1 North America Overactive Bladder Treatment Market Size (M USD) by Regions (2018-2025)
8.1.1 United States Overactive Bladder Treatment Revenue and Growth Rate (2018-2025)
8.1.2 Canada Overactive Bladder Treatment Revenue and Growth Rate (2018-2025)
8.1.3 Mexico Overactive Bladder Treatment Revenue and Growth Rate (2018-2025)
8.2 North America Overactive Bladder Treatment Market Size by Application (2018-2025)
8.3 North America Overactive Bladder Treatment Market Size by Product (2018-2025)
9 OVERACTIVE BLADDER TREATMENT DRUG MANUFACTURING COST ANALYSIS
9.1 Overactive Bladder Treatment Drug Raw Materials Analysis
9.2 Overactive Bladder Treatment Drug R&D Cost Analysis
9.2.1 Clinical Phase Costs
9.2.2 Capitalized Costs
9.3 Proportion of Manufacturing Cost Structure
9.3.1 Raw Materials
9.3.2 Labor Cost Analysis
9.3.3 Other Costs Analysis
9.3.4 Manufacturing Expenses
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 RESEARCH FINDING /CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Disclaimer
12.4 Author List
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Picture of Overactive Bladder Treatment
Figure North America Overactive Bladder Treatment Market Size (M USD) Status and Outlook (2013-2025)
Figure North America Market Overactive Bladder Treatment Revenue (M USD) Comparison by Regions 2013-2025
Figure North America Overactive Bladder Treatment Market Share by Regions (2013-2025)
Figure United States Overactive Bladder Treatment Market Size (M USD) and Growth Rate (2013-2018)
Figure Canada Overactive Bladder Treatment Market Size (M USD) and Growth Rate (2013-2018)
Figure Mexico Overactive Bladder Treatment Market Size (M USD) and Growth Rate (2013-2018)
Figure North America Overactive Bladder Treatment Revenue (M USD) Comparison by Product (2013-2025)
Figure North America Overactive Bladder Treatment Revenue Market Share by Product (2013-2025)
Figure North America Overactive Bladder Treatment Revenue Market Share (%) by Product in 2017
Figure Product Picture of Anticholinergics
Figure Anticholinergics Market Size (M USD) and Growth Rate (2013-2018)
Figure Product Picture of Mirabegron
Figure Mirabegron Market Size (M USD) and Growth Rate (2013-2018)
Figure Product Picture of Botox
Figure Botox Market Size (M USD) and Growth Rate (2013-2018)
Figure North America Overactive Bladder Treatment Market Size (M USD) Comparison by Application (2013-2025)
Figure North America Overactive Bladder Treatment Market Share by Application in 2017
Figure Overactive Bladder Treatment Market Size (M USD) and Growth Rate in Idiopathic Overactive Bladder (2013-2018)
Figure Overactive Bladder Treatment Market Size (M USD) and Growth Rate in Neurogenic Overactive Bladder (2013-2018)
Table North America Overactive Bladder Treatment Revenue (M USD) by Players (2013-2018)
Table North America Overactive Bladder Treatment Revenue Market Share (%) by Players (2013-2018)
Figure North America Overactive Bladder Treatment Market Share by Players in 2017
Figure North America Top 3 Players Overactive Bladder Treatment Market Share in 2017
Table Product Category of Overactive Bladder Treatment Players
Table Astellas Pharma Company Profile
Table Overactive Bladder Treatment Information of Astellas Pharma (Vesicare)
Table Overactive Bladder Treatment Information of Astellas Pharma (Betanis / Myrbetriq / BETMIGA)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Astellas Pharma (2013-2018)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Astellas Pharma (2013-2018)
Table Allergan Company Profile
Table Overactive Bladder Treatment Information of Allergan (Botox)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Allergan (2013-2018)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Allergan (2013-2018)
Table Pfizer Company Profile
Table Overactive Bladder Treatment Information of Pfizer (Toviaz)
Table Overactive Bladder Treatment Information of Pfizer (Toviaz)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Pfizer (2013-2018)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Pfizer (2013-2018)
Table Teva Pharmaceutical (Actavis) Company Profile
Table Overactive Bladder Treatment Information of Teva Pharmaceutical (Oxytrol)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Teva Pharmaceutical (Actavis) (2013-2018)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Teva Pharmaceutical (Actavis) (2013-2018)
Table Johnson & Johnson Company Profile
Table Overactive Bladder Treatment Information of Johnson & Johnson (Ditropan and Ditropan XL)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Johnson & Johnson (2013-2018)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Johnson & Johnson (2013-2018)
Table North America Overactive Bladder Treatment Market Size by Product (2013-2018)
Figure North America Overactive Bladder Treatment Revenue Market Share (%) by Product (2013-2018)
Figure North America Overactive Bladder Treatment Market Share by Product in 2017
Table North America Overactive Bladder Treatment Market Size by Application (2013-2018)
Figure North America Overactive Bladder Treatment Revenue Market Share (%) by Application (2013-2018)
Figure North America Overactive Bladder Treatment Market Share by Application in 2017
Table Major Buyers of Overactive Bladder Treatment
Figure USA Overactive Bladder Treatment Market Size and Growth Rate (2013-2018)
Table USA Overactive Bladder Treatment Market Size by Types (2013-2018)
Figure USA Overactive Bladder Treatment Revenue Market Share (%) by Types (2013-2018)
Figure USA Overactive Bladder Treatment Market Share by Types in 2017
Table USA Overactive Bladder Treatment Market Size by Application (2013-2018)
Figure USA Overactive Bladder Treatment Revenue Market Share (%) by Application (2013-2018)
Figure USA Overactive Bladder Treatment Market Share by Application in 2017
Figure Canada Overactive Bladder Treatment Market Size and Growth Rate (2013-2018)
Table Canada Overactive Bladder Treatment Market Size by Types (2013-2018)
Figure Canada Overactive Bladder Treatment Revenue Market Share (%) by Types (2013-2018)
Figure Canada Overactive Bladder Treatment Market Share by Types in 2017
Table Canada Overactive Bladder Treatment Market Size by Application (2013-2018)
Figure Canada Overactive Bladder Treatment Revenue Market Share (%) by Application (2013-2018)
Figure Canada Overactive Bladder Treatment Market Share by Application in 2017
Figure Mexico Overactive Bladder Treatment Market Size and Growth Rate (2013-2018)
Table Mexico Overactive Bladder Treatment Market Size by Types (2013-2018)
Figure Mexico Overactive Bladder Treatment Revenue Market Share (%) by Types (2013-2018)
Figure Mexico Overactive Bladder Treatment Market Share by Types in 2017
Table Mexico Overactive Bladder Treatment Market Size by Application (2013-2018)
Figure Mexico Overactive Bladder Treatment Revenue Market Share (%) by Application (2013-2018)
Figure Mexico Overactive Bladder Treatment Market Share by Application in 2017
Figure North America Overactive Bladder Treatment Market Size and Growth Rate (Value) (2018-2025)
Table North America Overactive Bladder Treatment Market Size by Regions (2018-2025)
Figure North America Overactive Bladder Treatment Market Share by Regions (2018-2025)
Figure North America Overactive Bladder Treatment Market Share by Regions in 2025
Figure United States Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2018-2025)
Figure Canada Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2018-2025)
Figure Mexico Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2018-2025)
Table North America Overactive Bladder Treatment Market Size by Application (2018-2025)
Figure North America Overactive Bladder Treatment Market Size by Application (2018-2025)
Figure North America Overactive Bladder Treatment Market Size by Application in 2025
Table North America Overactive Bladder Treatment Market Size by Product (2018-2025)
Figure North America Overactive Bladder Treatment Market Size by Product (2018-2025)
Figure North America Overactive Bladder Treatment Market Size by Product in 2025
Figure Typical Phases from Research to the Market for a Drug Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Overactive Bladder Treatment Drug
Figure USA Labor Cost Analysis 2012-2016
Figure Cost of Employing a Factory Worker
Table Average Price of Electricity to Ultimate Customers 2007-2016
Figure Global GDP Growth Rate for 2016
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2016-2017
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Picture of Overactive Bladder Treatment
Figure North America Overactive Bladder Treatment Market Size (M USD) Status and Outlook (2013-2025)
Figure North America Market Overactive Bladder Treatment Revenue (M USD) Comparison by Regions 2013-2025
Figure North America Overactive Bladder Treatment Market Share by Regions (2013-2025)
Figure United States Overactive Bladder Treatment Market Size (M USD) and Growth Rate (2013-2018)
Figure Canada Overactive Bladder Treatment Market Size (M USD) and Growth Rate (2013-2018)
Figure Mexico Overactive Bladder Treatment Market Size (M USD) and Growth Rate (2013-2018)
Figure North America Overactive Bladder Treatment Revenue (M USD) Comparison by Product (2013-2025)
Figure North America Overactive Bladder Treatment Revenue Market Share by Product (2013-2025)
Figure North America Overactive Bladder Treatment Revenue Market Share (%) by Product in 2017
Figure Product Picture of Anticholinergics
Figure Anticholinergics Market Size (M USD) and Growth Rate (2013-2018)
Figure Product Picture of Mirabegron
Figure Mirabegron Market Size (M USD) and Growth Rate (2013-2018)
Figure Product Picture of Botox
Figure Botox Market Size (M USD) and Growth Rate (2013-2018)
Figure North America Overactive Bladder Treatment Market Size (M USD) Comparison by Application (2013-2025)
Figure North America Overactive Bladder Treatment Market Share by Application in 2017
Figure Overactive Bladder Treatment Market Size (M USD) and Growth Rate in Idiopathic Overactive Bladder (2013-2018)
Figure Overactive Bladder Treatment Market Size (M USD) and Growth Rate in Neurogenic Overactive Bladder (2013-2018)
Table North America Overactive Bladder Treatment Revenue (M USD) by Players (2013-2018)
Table North America Overactive Bladder Treatment Revenue Market Share (%) by Players (2013-2018)
Figure North America Overactive Bladder Treatment Market Share by Players in 2017
Figure North America Top 3 Players Overactive Bladder Treatment Market Share in 2017
Table Product Category of Overactive Bladder Treatment Players
Table Astellas Pharma Company Profile
Table Overactive Bladder Treatment Information of Astellas Pharma (Vesicare)
Table Overactive Bladder Treatment Information of Astellas Pharma (Betanis / Myrbetriq / BETMIGA)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Astellas Pharma (2013-2018)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Astellas Pharma (2013-2018)
Table Allergan Company Profile
Table Overactive Bladder Treatment Information of Allergan (Botox)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Allergan (2013-2018)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Allergan (2013-2018)
Table Pfizer Company Profile
Table Overactive Bladder Treatment Information of Pfizer (Toviaz)
Table Overactive Bladder Treatment Information of Pfizer (Toviaz)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Pfizer (2013-2018)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Pfizer (2013-2018)
Table Teva Pharmaceutical (Actavis) Company Profile
Table Overactive Bladder Treatment Information of Teva Pharmaceutical (Oxytrol)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Teva Pharmaceutical (Actavis) (2013-2018)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Teva Pharmaceutical (Actavis) (2013-2018)
Table Johnson & Johnson Company Profile
Table Overactive Bladder Treatment Information of Johnson & Johnson (Ditropan and Ditropan XL)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Johnson & Johnson (2013-2018)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Johnson & Johnson (2013-2018)
Table North America Overactive Bladder Treatment Market Size by Product (2013-2018)
Figure North America Overactive Bladder Treatment Revenue Market Share (%) by Product (2013-2018)
Figure North America Overactive Bladder Treatment Market Share by Product in 2017
Table North America Overactive Bladder Treatment Market Size by Application (2013-2018)
Figure North America Overactive Bladder Treatment Revenue Market Share (%) by Application (2013-2018)
Figure North America Overactive Bladder Treatment Market Share by Application in 2017
Table Major Buyers of Overactive Bladder Treatment
Figure USA Overactive Bladder Treatment Market Size and Growth Rate (2013-2018)
Table USA Overactive Bladder Treatment Market Size by Types (2013-2018)
Figure USA Overactive Bladder Treatment Revenue Market Share (%) by Types (2013-2018)
Figure USA Overactive Bladder Treatment Market Share by Types in 2017
Table USA Overactive Bladder Treatment Market Size by Application (2013-2018)
Figure USA Overactive Bladder Treatment Revenue Market Share (%) by Application (2013-2018)
Figure USA Overactive Bladder Treatment Market Share by Application in 2017
Figure Canada Overactive Bladder Treatment Market Size and Growth Rate (2013-2018)
Table Canada Overactive Bladder Treatment Market Size by Types (2013-2018)
Figure Canada Overactive Bladder Treatment Revenue Market Share (%) by Types (2013-2018)
Figure Canada Overactive Bladder Treatment Market Share by Types in 2017
Table Canada Overactive Bladder Treatment Market Size by Application (2013-2018)
Figure Canada Overactive Bladder Treatment Revenue Market Share (%) by Application (2013-2018)
Figure Canada Overactive Bladder Treatment Market Share by Application in 2017
Figure Mexico Overactive Bladder Treatment Market Size and Growth Rate (2013-2018)
Table Mexico Overactive Bladder Treatment Market Size by Types (2013-2018)
Figure Mexico Overactive Bladder Treatment Revenue Market Share (%) by Types (2013-2018)
Figure Mexico Overactive Bladder Treatment Market Share by Types in 2017
Table Mexico Overactive Bladder Treatment Market Size by Application (2013-2018)
Figure Mexico Overactive Bladder Treatment Revenue Market Share (%) by Application (2013-2018)
Figure Mexico Overactive Bladder Treatment Market Share by Application in 2017
Figure North America Overactive Bladder Treatment Market Size and Growth Rate (Value) (2018-2025)
Table North America Overactive Bladder Treatment Market Size by Regions (2018-2025)
Figure North America Overactive Bladder Treatment Market Share by Regions (2018-2025)
Figure North America Overactive Bladder Treatment Market Share by Regions in 2025
Figure United States Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2018-2025)
Figure Canada Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2018-2025)
Figure Mexico Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2018-2025)
Table North America Overactive Bladder Treatment Market Size by Application (2018-2025)
Figure North America Overactive Bladder Treatment Market Size by Application (2018-2025)
Figure North America Overactive Bladder Treatment Market Size by Application in 2025
Table North America Overactive Bladder Treatment Market Size by Product (2018-2025)
Figure North America Overactive Bladder Treatment Market Size by Product (2018-2025)
Figure North America Overactive Bladder Treatment Market Size by Product in 2025
Figure Typical Phases from Research to the Market for a Drug Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Overactive Bladder Treatment Drug
Figure USA Labor Cost Analysis 2012-2016
Figure Cost of Employing a Factory Worker
Table Average Price of Electricity to Ultimate Customers 2007-2016
Figure Global GDP Growth Rate for 2016
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2016-2017
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
